Trials / Recruiting
RecruitingNCT07233863
Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
Effectiveness of Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- Sponsor
- Dharmais National Cancer Center Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
Detailed description
In the intervention group, LVB was performed with intima-to-intima coaptation using the super microsurgery technique. The anastomosis was between the afferent lymphatic vessel and the recipient vein. The upper extremity lymphedema (UEL) index and indocyanine green (ICG) lymphography are utilized to evaluate the progression of lymphedema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lymphovenous bypass (LVB) | The Lymphovenous Bypass (LVB) procedure in this study is a microsurgical supermicrosurgery-based intervention specifically designed for the secondary prevention of breast cancer-related lymphedema following axillary lymph node dissection. |
Timeline
- Start date
- 2024-03-18
- Primary completion
- 2027-03-21
- Completion
- 2028-03-21
- First posted
- 2025-11-18
- Last updated
- 2025-11-18
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT07233863. Inclusion in this directory is not an endorsement.